Fingerprint
Dive into the research topics of 'Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically